RADNOR, PA — Avantor, Inc. (NYSE: AVTR) said President and Chief Executive Emmanuel Ligner will present at the 44th Annual J.P. Morgan Healthcare Conference, giving investors a close look at a company that sits at the backbone of the global life sciences industry.
Ligner is scheduled to speak at approximately 8:15 a.m. Pacific Standard Time on Wednesday, January 14, 2026. The presentation will be available via a live audio webcast through the Events & Presentations section of Avantor’s investor website at ir.avantorsciences.com, with a replay posted for 30 days.
The appearance places Avantor alongside the healthcare and biotechnology sector’s most closely watched names at one of the industry’s most influential investor conferences, a venue where strategy, capital allocation, and growth outlooks often set the tone for the year ahead.
Avantor is not a drug developer, but its reach across the life sciences ecosystem is vast. The company supplies mission-critical products and services used in research, development, and manufacturing for pharmaceuticals, biotechnology, diagnostics, and advanced technologies. Its tools, chemicals, and materials are embedded in laboratories and production facilities at more than 300,000 customer locations across 180 countries, making it one of the quiet enablers behind many of the world’s most important scientific and medical breakthroughs.
For investors, the company’s appeal lies in that embedded position. As global spending on drug development, biologics manufacturing, and advanced therapies continues to grow, Avantor benefits not from a single molecule or clinical trial, but from the volume and complexity of scientific work itself. That model can offer more stable, diversified revenue than the high-risk, high-reward economics of drug discovery.
Ligner’s JPMorgan presentation is expected to give the market an updated view of how Avantor plans to capitalize on those trends, including its strategy for serving biopharma customers, managing costs, and navigating a highly competitive life-sciences supply chain.
In a sector where innovation often grabs headlines, Avantor’s message at JPMorgan will likely be simpler but no less consequential: when science moves forward, the company intends to be there supplying the tools that make it possible.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.